Healthcare

The deal is valued at $950 million.

CHI comprises three segments: hard empty capsules, dosage form solutions, and health ingredients.

The investment will enable Saisystems to accelerate its technology roadmap.

A look at the active pharmaceutical ingredients (API) sector, which has attracted the likes of Astorg, EQT, TA Associates and New Mountain Capital; an agreement by American Securities to sell a medical components manufacturer; insights learned from advisory services firm BDO about the life sciences IPO and M&A market.

Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.

Astorg's portfolio company Solabia has acquired three complementary businesses.

Steve Wise spoke with PE Hub's Mary Kathleen (MK) Flynn at PEI Group’s NEXUS 2026 summit.

US BioTek Laboratories is a Shoreline, Washington-based functional laboratory specializing in advanced immunological and integrative diagnostics.

The transaction is expected to close in the second quarter of 2026.

Corstasis shareholders also will be eligible to receive a total of up to an additional $180 million upon the attainment of certain regulatory and commercial milestones.